| Literature DB >> 35203178 |
František Zigo1, Zuzana Farkašová1, Jana Výrostková2, Ivana Regecová2, Silvia Ondrašovičová3, Mária Vargová4, Naďa Sasáková4, Ewa Pecka-Kielb5, Šárka Bursová6, David Sandor Kiss7.
Abstract
This study investigated 960 Slovak and Czech spotted cattle from four different conventional (non-organic) dairy herds located in Eastern Slovakia and Czechia during early lactation (14-100 days after calving). Dairy cows were examined clinically; milk from fore-stripping of each udder quarter was subjected to sensory examination and assessed by the California mastitis test (CMT), and laboratory analyses of bacterial pathogens in milk, including virulence factors, were conducted. Positive CMT scores (1-3) for one or more quarters were detected in 271 (28.2%) of the examined animals. Out of 230 infected milk samples, representing 24.0% of all dairy cows, staphylococci (59.1% of positive findings) were the most commonly isolated organisms, followed by E. coli (11.3%), streptococci Str. uberis (9.1%) and Str. agalactiae (3.4%), and enterococci (6.1%). From 136 isolates of S. aureus (38 isolates) and non-aureus staphylococci (NAS; 98 isolates), virulence factors and their resistance to 14 antimicrobials were detected using the disk diffusion method, with PCR detection of the methicillin resistance gene, mecA. An increased incidence of clinical and chronic forms of mastitis has been reported in mastitic cows in which staphylococci, especially S. aureus and NAS (S. chromogenes, S. warneri, and S. xylosus), have been detected and compared to other isolated udder pathogens. From those species, S. aureus and isolates of NAS mentioned above showed multiple virulence factors that are more likely to hydrolyze DNA, hemolysis, produce gelatinase and biofilm, and have multi-drug resistance as compared to other less virulent staphylococci. Generally, the isolated staphylococci showed 77.2% resistance to one or more antimicrobials, in particular to aminoglycosides, β-lactams, macrolides, or cephalosporins. Isolates that showed the ability to form a biofilm were more resistant to more than one antimicrobial than isolates without biofilm production. Multi-drug resistance to three or more antimicrobial classes was recorded in 16 isolates (11.7%), and the presence of the mecA gene was also confirmed in two isolates of S. aureus and two species of NAS.Entities:
Keywords: antibiotics; biofilm; early lactation; mastitis; methicillin resistance gene; non-aureus staphylococci
Year: 2022 PMID: 35203178 PMCID: PMC8868196 DOI: 10.3390/ani12040470
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Figure 1DNase test and biofilm production on Congo Red agar for staphylococcal detection. Source: Zigo et al. [6].
Figure 2Prevalence of mastitis in monitored dairy herds during early lactation. Note: CZ 1–2: dairy farms situated in Czechia; SK 1–2: dairy farms situated in Slovakia. Subclinical mastitis: no signs are observed, the udder and milk appear normal, but an infection is still present with a positive CMT score and an increased SCC. Clinical mastitis: signs that are mild, moderate, or severe. Chronic mastitis: detected based on history (previous treatment) of clinical examination of the udder and positive CMT score.
Udder pathogens isolated from milk samples of four monitored dairy herds.
| Pathogens | Number of Isolates | % | Clinical IMI 1 | Chronic IMI 2 | Subclinical IMI 3 | ||
|---|---|---|---|---|---|---|---|
| CM1 | CM2 | CM3 | |||||
| NAS | 98 | 42.6 | 28/12.2 | 7/3.0 | 2/1.3 | 8/3.5 | 53/23.0 |
|
| 38 | 16.5 | 10/4.3 | 5/2.2 | 3/1.3 | 11/4.7 | 9/3.9 |
|
| 26 | 11.2 | 5/2.2 | 2/0.9 | 0/0 | 2/0.9 | 17/7.4 |
|
| 21 | 9.1 | 4/1.7 | 4/1.7 | 1/0.4 | 7/3.0 | 5/2.2 |
|
| 8 | 3.4 | 0/0 | 3/1.3 | 0/0 | 3/1.3 | 2/0.9 |
| 10 | 4.3 | 4/1.7 | 0/0 | 0/0 | 0/0 | 6/2.6 | |
| 14 | 6.1 | 2/0.9 | 1/0.4 | 0/0 | 0/0 | 11/4.8 | |
| Mixed infection 4 | 15 | 6.5 | 4/1.7 | 2/0.9 | 0/0 | 4/1.7 | 5/2.2 |
| Total | 230 | 100 | 57/24.7 | 24/10.5 | 6/2.6 | 35/15.2 | 108/46.9 |
Note: Clinical IMI 1—clinical intramammary infection (IMI), including mild (CM1), moderate (CM2) and severe forms (CM3) of mastitis; Chronic IMI 2—chronic or persistent intramammary infection; Subclinical IMI 3—subclinical intramammary infection. Mixed infection 4—include a mix infection of two bacterial pathogens.
The role of S. aureus and NAS in the form of mastitis and their virulence factors.
| IMI 1/Number | Hemolysins 2 | DNAse 3 | Gelatinase | Biofilm | Testing Value | ||
|---|---|---|---|---|---|---|---|
| clinical (18) | 6α/4δ/1β | 14 | 15 | 9 | 2 | 5.447 * | |
| chronic (11) | 3α/2δ/2β | 8 | 7 | 7 | 0 | ||
| subclinical (9) | 3α/1β | 6 | 7 | 5 | 0 | ||
| clinical (11) | 4β/3δ | 3 | 4 | 4 | 0 | 3.204 * | |
| chronic (4) | 3β | 1 | 1 | 2 | 1 | ||
| subclinical (7) | 2β/2δ | 1 | 1 | 2 | 0 | ||
| clinical (9) | 4δ/2β | 2 | 2 | 4 | 1 | 2.688 * | |
| chronic (3) | 3β | 0 | 0 | 1 | 0 | ||
| subclinical (8) | 3β/1δ | 2 | 0 | 2 | 0 | ||
| clinical (7) | 2δ/2β | 2 | 0 | 3 | 0 | 2.255 * | |
| chronic (1) | 0 | 0 | 0 | 0 | 0 | ||
| subclinical (10) | 4β/1δ | 0 | 0 | 2 | 0 | ||
| clinical (2) | 1δ | 0 | 0 | 1 | 0 | 1.012 | |
| subclinical (7) | 2δ | 0 | 0 | 2 | 0 | ||
| clinical (4) | 2β/1δ | 1 | 0 | 2 | 0 | 0.742 | |
| subclinical (3) | 0 | 0 | 0 | 0 | 0 | ||
| clinical (2) | 2δ | 0 | 0 | 0 | 0 | 0.401 | |
| subclinical (4) | 0 | 0 | 0 | 0 | 0 | ||
| clinical (2) | 1β | 0 | 0 | 1 | 0 | 0.851 | |
| subclinical (4) | 2δ | 0 | 0 | 0 | 0 | ||
| clinical (0) | 0 | 0 | 0 | 0 | 0 | 0.332 | |
| subclinical (10) | 1δ | 0 | 0 | 1 | 0 |
IMI 1—number of isolates and their influence on type of mastitis; hemolysines 2—production of hemolysin type α, β or δ; DNAse 3—ability of staphylococci to hydrolyze DNA; * Chi-squared test significance level α = 0.05; critical value χ2 = 2.206; Testing value (G) and statistical independence of virulence factors in isolated staphylococci was confirmed when G > χ2; the independence was not statistically significant when testing value was G < χ2.
Antimicrobial resistance of S. aureus and NAS isolated from mastitic milk samples.
| Bacterial Strains | Other NAS * | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Antibiotic/Resistance | % |
| % |
| % |
| % |
| % |
|
| Penicillin | 18.4 | 7 | 13.6 | 3 | 20.0 | 4 | 11.1 | 2 | 10.3 | 4 |
| Amoxicillin | 18.4 | 7 | 18.1 | 4 | 15.0 | 3 | 11.1 | 2 | 10.3 | 4 |
| Ampicillin | 23.6 | 9 | 18.1 | 4 | 20.0 | 4 | 16.7 | 3 | 15.4 | 6 |
| Amox. + clav. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Oxacillin | 13.2 | 5 | 13.6 | 3 | 15.0 | 3 | 11.1 | 2 | 5.1 | 2 |
| Cefoxitin | 10.5 | 4 | 9.0 | 2 | 10.0 | 2 | 0 | 0 | 0 | 0 |
| Cephalexin | 10.5 | 4 | 9.0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ciprofloxacin | 10.5 | 4 | 9.0 | 2 | 10.0 | 2 | 11.1 | 2 | 0 | 0 |
| Lincomycin | 13.2 | 5 | 9.0 | 2 | 5.0 | 1 | 11.1 | 2 | 7.7 | 3 |
| Neomycin | 29.0 | 11 | 18.1 | 4 | 20.0 | 4 | 16.7 | 3 | 15.4 | 6 |
| Novobiocin | 18.4 | 7 | 18.1 | 4 | 10.0 | 2 | 77.8 | 14 | 7.7 | 3 |
| Rifaximin | 5.3 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Streptomycin | 29.0 | 11 | 27.3 | 6 | 25.0 | 5 | 11.1 | 2 | 17.9 | 7 |
| Tetracycline | 5.3 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Note: Other NAS*: S. epidermidis, S. haemolyticus, S. capitis, S. piscifermentans, S. hyicus; n—number of tested isolates.
Phenotypic resistance profile in isolates of Staphylococcus spp. (n = 136) from mastitic cows.
| Number Group of Antimicrobials | Phenotypic Resistance Profile | Number of Isolates | % of Isolates |
|---|---|---|---|
| 0 | 30 | 22.1 | |
| 1 | STR | 11 | 8.1 |
| 1 | PEN | 9 | 6.6 |
| 1 | NMC | 8 | 5.9 |
| 1 | AMX | 7 | 5.1 |
| 1 | NVB | 6 | 4.4 |
| 1 | AMP | 6 | 4.4 |
| 1 | LNC | 4 | 2.9 |
| 2 | NMC, STR | 9 | 6.6 |
| 2 | AMP, NVB | 4 | 2.9 |
| 2 | CPR, NVB | 2 | 2.2 |
| 2 | LNC, NVB | 2 | 1.5 |
| 3 | PEN, AMX, OXA | 4 | 2.9 |
| 3 | AMP, AMX, OXA | 3 | 2.2 |
| 3 | PEN, LNC, NVB | 2 | 1.5 |
| 3 | AMP, OXA, NMC | 3 | 2.2 |
| 3 | AMP, AMX, NVB | 4 | 2.9 |
| 3 | PEN, AMX, AMC, | 2 | 1.5 |
| 3 * | NVB, LNC, STR | 4 | 2.9 |
| 4 | AMP, CEP, FOX, OXA | 3 | 2.2 |
| 4 * | RFX, CPR, STR, TET | 2 | 1.5 |
| 4 * | CPR, LNC, NMC, NVB | 3 | 2.2 |
| 4 * | NVB, CPR, NMC, STR | 2 | 1.5 |
| 4 * | AMP, CEP, FOX, PEN | 3 | 2.2 |
| 5 * | OXA, FOX, AMP, NMC, STR | 2 | 1.5 |
| Total ATBs resistant isolates | 105 | 77.2 | |
Note: * MDR—multi drug resistant isolates to three or more antimicrobial classes; AMX—amoxicillin, AMC—amoxicillin+clavulanat acid, AMP—ampicillin, CEP—cephalexin, CPR—ciprofloxacin, FOX—cefoxitin, LNC—lincomycin, NMC—neomycin, NVB—novobiocin, OXA—oxacillin, PEN—penicillin, RFX—rifaximin, STR—streptomycin, TET—tetracycline.
Figure 3Comparison of resistance to more than one antimicrobial in isolates forming or non-forming biofilm at a time. Note: n—number of resistant isolates to more than one antimicrobial.
Figure 4Detection of mecA gene in Staphylococcus spp. isolates isolated from infected raw milk samples using the PCR method (527 bp). L: 100 bp ladder; Line 1: isolate S. xylosus without mecA gene; Line 2: isolate S. capitis without mecA gene; Line 3: isolate S. chromogenes with mecA gene; Line 4: isolate S. warneri with mecA gene; Lines 5 and 6: isolate S. aureus with mecA gene; Line 7: isolate S. haemolyticus without mecA gene; Line 8: reference strain CCM 4750 S. aureus (positive control); Line 9: water (negative control).